The CAF01 adjuvant has previously been shown to be safe for human use and to be a potent adjuvant for several vaccine antigens. In the present work, we sought to optimize the Leishmania amazonensis antigens (LaAg) intranasal vaccine in an attempt to enhance the protective immune responses against Leishmania (infantum) chagasi by using the CAF01 association. LaAg/CAF01 vaccinated mice that were challenged 15 days after booster dose with L. (infantum) chagasi showed a significant reduction in their parasite burden in both the spleen and liver, which is associated with an increase in specific production of IFN-γ and nitrite, and a decrease in IL-4 production. In addition, LaAg/CAF01 intranasal delivery was able to increase lymphoproliferative immune responses after parasite antigen recall. These results suggest the feasibility of using the intranasal route for the delivery of crude antigens and of a human-compatible adjuvant against visceral leishmaniasis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1017/S0031182015001250 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Detection of Leishmania infantum and Leishmania amazonensis in Bats From Endemic and Non-endemic Areas of São Paulo State, Brazil.
Zoonoses Public Health
December 2024
Department of Animal Production and Preventive Veterinary Medicine, São Paulo State University, Botucatu, Brazil.
Aims: Leishmaniasis is an endemic disease in several regions of Brazil, a tropical country that presents specific environmental conditions that contribute to the development of phlebotomine vectors. This study aimed to detect Leishmania species in naturally infected bats from 17 municipalities in the São Paulo state.
Methods And Results: Spleen and liver samples from 203 bats were analysed by real-time PCR and confirmed by conventional PCR followed by gene sequencing.
Phlebotomine sand fly (Diptera: Psychodidae) fauna, blood meal source, and detection of Leishmania (Kinetoplastida: Trypanosomatidae) DNA in the Gurupi Biological Reserve, Eastern Amazon, Brazil.
J Med Entomol
November 2024
Universidade Estadual do Maranhão, Programa de Biodiversidade, Ambiente e Saúde (PPGBAS), Laboratório de Entomologia Médica (LABEM), Caxias, Maranhão, Brazil.
This study was conducted in the Gurupi Biological Reserve (REBIO-Gurupi), the largest area of Amazon rainforest in Maranhão State, Brazil. The objectives were to survey the sand fly (Diptera: Psychodidae) fauna of REBIO-Gurupi, identify blood meal sources, and investigate the presence of Leishmania (Ross, 1903) (Kinetoplastida: Trypanosomatidae) DNA. Individuals were collected using Centers for Disease Control (CDC) light traps and black and white Shannon traps in May and Jun 2022 and Jan 2023.
View Article and Find Full Text PDFIn vitro evaluation against Leishmania amazonensis and Leishmania chagasi of medicinal plant species of interest to the Unified Health System.
An Acad Bras Cienc
July 2024
Universidade Federal de Alagoas, Instituto de Ciências Biológicas e da Saúde, Laboratório de Farmacologia e Imunologia, Av. Lourival Melo Mota, s/n, Tabuleiro do Martins, 57072-900 Maceió, AL, Brazil.
Leishmaniasis is a disease of public health relevance that demands new therapeutic alternatives due to the toxicity of conventional treatments. In this study, 27 plants of interest to the Unified Health System (SUS) were evaluated for cytotoxicity in macrophages, leishmanicidal activity and production of nitric oxide (NO). None of the species demonstrated cytotoxicity to macrophages (CC50 >100 μg/mL).
View Article and Find Full Text PDFLeishmania infantum infection modulates messenger RNA, microRNA and long non-coding RNA expression in human neutrophils in vitro.
PLoS Negl Trop Dis
July 2024
Department of Production and Animal Health, São Paulo State University (Unesp), School of Veterinary Medicine, Araçatuba, São Paulo, Brazil.
In the Americas, L. infantum (syn. chagasi) is the main cause of human visceral leishmaniasis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!